Maze Therapeutics logo

Maze Therapeutics Share Price (NASDAQ: MAZE)

$14.5

0.23

(1.61%)

Last updated on

Check the interactive Maze Therapeutics Stock chart to analyse performance

Maze Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$13.90
    Today's High:$14.51

    Day's Volatility :4.2%

  • 52 Weeks Low:$6.71
    52 Weeks High:$19.19

    52 Weeks Volatility :65.03%

Maze Therapeutics Stock Returns

PeriodMaze TherapeuticsIndex (Russel 2000)
3 Months
19.75%
0.0%
6 Months
31.25%
0.0%
1 Year
-9.15%
0.0%
3 Years
-9.15%
-4.7%

Maze Therapeutics Key Stats

Check Maze Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$14.27
Open
$14.18
Today's High
$14.51
Today's Low
$13.9
Market Capitalization
$525.3M
Today's Volume
$358.4K
52 Week High
$19.19
52 Week Low
$6.71
Revenue TTM
$167.5M
EBITDA
$67.8M
Earnings Per Share (EPS)
$-0.42
Profit Margin
32.97%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

Stock Returns calculator for Maze Therapeutics Stock including INR - Dollar returns

The Maze Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Maze Therapeutics investment value today

Current value as on today

₹96,193

Returns

₹3,807

(-3.81%)

Returns from Maze Therapeutics Stock

₹9,091 (-9.09%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Maze Therapeutics Stock

-63%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Maze Therapeutics Stock from India on INDmoney has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Maze Therapeutics Stock

Rating
Trend

Maze Therapeutics Stock Insights

  • Price Movement

    In the last 7 days, MAZE stock has moved up by 7.4%

Maze Therapeutics Technicals Summary

Sell

Neutral

Buy

Maze Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Maze Therapeutics Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Maze Therapeutics logo
-2.75%
31.25%
-9.15%
-9.15%
-9.15%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Maze Therapeutics

Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States. Its lead programs include MZE829, an oral small molecule inhibitor of apolipoprotein L1, or APOL1, which is in phase II clinical trial for the treatment of patients with APOL1 kidney disease; and MZE782, an oral small molecule inhibitor of the solute transporter SLC6A19, which is in phase I clinical trial for the treatment of chronic kidney disease. The company also offers MZE001, a clinical program for the treatment of Pompe disease. Maze Therapeutics, Inc. was formerly known as Modulus Therapeutics, Inc. and changed its name to Maze Therapeutics, Inc. in September 2018. The company was incorporated in 2017 and is based in South San Francisco, California.
Organization
Maze Therapeutics
Employees
125
CEO
Dr. Jason V. Coloma M.B.A., M.P.H., Ph.D.
Industry
Miscellaneous

Key Management of Maze Therapeutics

NameTitle
Dr. Jason V. Coloma M.B.A., M.P.H., Ph.D.
CEO & Director
Dr. Harold S. Bernstein M.D., Ph.D.
President of Research & Development and Chief Medical Officer
Ms. Courtney J. Phillips J.D.
General Counsel & Corporate Secretary
Ms. Amy Bachrodt
Senior VP of Finance & CFO
Mr. Vipin Vijayakumar
Vice President of R&D Infrastructure and Operations
Mr. Matt Krause
Senior Vice President of Human Resources
Mr. Atul Dandekar
Chief Strategy & Business Officer
Ms. Nazila Habibizad
Senior Vice President of Technical Operations & Supply Chain
Mr. Maarten Hoek
Senior Vice President of Research
Mr. Winston Tse
Senior Vice President of Drug Discovery

Important FAQs about investing in MAZE Stock from India :

What is Maze Therapeutics share price today?

Maze Therapeutics share price today is $14.50 as on at the close of the market. Maze Therapeutics share today touched a day high of $14.51 and a low of $13.90.

What is the 52 week high and 52 week low for Maze Therapeutics share?

Maze Therapeutics share touched a 52 week high of $19.19 and a 52 week low of $6.71. Maze Therapeutics stock price today i.e. is closed at $14.50, lower by 24.44% versus the 52 week high.

How to invest in Maze Therapeutics Stock (MAZE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Maze Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Maze Therapeutics Shares that will get you 0.1034 shares as per Maze Therapeutics share price of $14.50 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Maze Therapeutics Stock (MAZE) from India?

Indian investors can start investing in Maze Therapeutics (MAZE) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Maze Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Maze Therapeutics share’s latest price of $14.50 as on August 30, 2025 at 1:29 am IST, you will get 0.6897 shares of Maze Therapeutics. Learn more about fractional shares .

What are the returns that Maze Therapeutics has given to Indian investors in the last 5 years?

Maze Therapeutics stock has given -9.15% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?